Despite manufacturing and cost barriers, cell and gene therapies have become a major focus in biopharma investment, fostering cutting-edge innovation and enabling new hope for patients worldwide. https://xelleratherapeutics.blogspot.com/2025/06/impact-of-cell-and-gene-therapy.html